James Aloysius Brady
CIK 1916987 · last filed 2026-06-05
James Aloysius Brady is a corporate insider who has filed 9 SEC Form 4 insider transactions across 2 companies since 2022. The most recent filing, for XERS, was dated Jun 5, 2026. Across all open-market trades the lifetime net is −$70.9K, making them a net seller over the disclosed history. Current disclosed insider exposure totals $769.7K across reported positions.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
$769.7K
2
9
-$70.9K
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| XERS | Director | 113,359 | $6.79 | $769.7K | -$60.0K | 3 | 2026-06-05 |
| Verona Pharma plc (VRNA) Delisted | Director | 0 | $106.91 | $0 | -$10.8K | 6 | 2025-10-08 |
Recent Filings
9 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2026-06-05 | XERS | Grant (A) | +24,193 | $0 | EDGAR |
| 2026-04-01 | XERS | Sell (S) | −10,834 | -$60.0K | EDGAR |
| 2025-10-08 | Verona Pharma plc (VRNA) Delisted | Mixed | −23,176 | $0 | EDGAR |
| 2025-08-05 | Verona Pharma plc (VRNA) Delisted | Mixed | +23,176 | -$10.8K | EDGAR |
| 2025-04-29 | Verona Pharma plc (VRNA) Delisted | Grant (A) | — | $0 | EDGAR |
| 2025-03-28 | XERS | Grant (A) | +100,000 | $0 | EDGAR |
| 2024-04-30 | Verona Pharma plc (VRNA) Delisted | Grant (A) | — | $0 | EDGAR |
| 2023-04-28 | Verona Pharma plc (VRNA) Delisted | Grant (A) | — | $0 | EDGAR |
| 2022-03-16 | Verona Pharma plc (VRNA) Delisted | Grant (A) | — | $0 | EDGAR |